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ABSTRACT Poor specificity may negatively impact rapid diagnostic test (RDT)-based
diagnostic strategies for malaria. We performed real-time PCR on a subset of sub-
jects who had undergone diagnostic testing with a multiple-antigen (histidine-rich
protein 2 and pan-lactate dehydrogenase pLDH [HRP2/pLDH]) RDT and microscopy.
We determined the sensitivity and specificity of the RDT in comparison to results of
PCR for the detection of Plasmodium falciparum malaria. We developed and evalu-
ated a two-step algorithm utilizing the multiple-antigen RDT to screen patients, fol-
lowed by confirmatory microscopy for those individuals with HRP2-positive (HRP2)/
pLDH-negative (pLDH) results. In total, dried blood spots (DBS) were collected from
276 individuals. There were 124 (44.9%) individuals with an HRP2/pLDH result, 94
(34.1%) with an HRP2/pLDH result, and 58 (21%) with a negative RDT result. The
sensitivity and specificity of the RDT compared to results with real-time PCR were
99.4% (95% confidence interval [CI], 95.9 to 100.0%) and 46.7% (95% CI, 37.7 to
55.9%), respectively. Of the 94 HRP2/pLDH results, only 32 (34.0%) and 35 (37.2%)
were positive by microscopy and PCR, respectively. The sensitivity and specificity of
the two-step algorithm compared to results with real-time PCR were 95.5% (95% CI,
90.5 to 98.0%) and 91.0% (95% CI, 84.1 to 95.2), respectively. HRP2 antigen bands
demonstrated poor specificity for the diagnosis of malaria compared to that of real-
time PCR in a high-transmission setting. The most likely explanation for this finding
is the persistence of HRP2 antigenemia following treatment of an acute infection.
The two-step diagnostic algorithm utilizing microscopy as a confirmatory test for in-
determinate HRP2/pLDH results showed significantly improved specificity with lit-
tle loss of sensitivity in a high-transmission setting.
KEYWORDS Plasmodium falciparum, antigen specificity, diagnostics, epidemiology,
malaria, rapid tests
Since 2010, the World Health Organization (WHO) has recommended that all sus-pected malaria cases have a parasite-based diagnosis, either by microscopy or a
rapid diagnostic test (RDT), prior to treatment with artemisinin-based combination
therapy (ACT) (1). While light microscopy is the traditional reference standard for the
diagnosis of malaria, RDTs are increasingly employed because they require minimal
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infrastructure, can be used by nonprofessional health workers, and provide an easy-
to-interpret result in only a few minutes (2, 3).
Multiple studies have demonstrated the cost-effectiveness of RDT-based diagnostic
strategies in all but the most extreme transmission scenarios (4–6). From a public health
perspective, RDTs have the potential to improve the case management of febrile illness
and slow the development of resistance to ACT by decreasing the number of inappro-
priate prescriptions (7, 8). Additionally, the diagnostic accuracy of RDTs should con-
ceivably motivate recognition and treatment of alternative causes of febrile illness (9)
as well as improve the quality of communicable disease surveillance (10).
The value of RDTs in practice, however, is dependent on a number of factors,
including the diagnostic validity of the RDT under field conditions, which can vary
by transmission setting. Modeling studies often assume that histidine-rich protein
2 (HRP2) RDTs will perform with a sensitivity and specificity of approximately 95% (5),
an estimate derived from results of WHO product testing (11) and a previous meta-
analysis (12). However, in routine practice, test performance may vary significantly from
these assumptions. Sensitivity can be affected by low parasite density (13, 14) although
the significance of any missed cases is of unclear clinical consequence outside elimi-
nation programs targeting asymptomatic parasite reservoirs. In contrast, poor specific-
ity is more likely to negatively impact the economic and public health benefits of
RDT-based diagnostic strategies. Frequent false-positive test results will lead to over-
treatment and diminish the intended value of RDTs.
We conducted a large, prospective study of severe malaria in western Uganda that
included multiple testing modalities for suspected malaria cases. All participants un-
derwent testing with an RDT and microscopy, and we performed real-time PCR on a
subset of subjects. In the manuscript, we report on the diagnostic validity of a multiple-
antigen RDT assay compared to that of PCR and microscopy and propose a novel
diagnostic algorithm, with the intent of improving the diagnostic specificity for malaria
diagnosis in resource-limited, peripheral health centers with limited laboratory capac-
ities.
RESULTS
Dried blood spots (DBS) were collected from 276 individuals. In total, there were 124
(44.9%) individuals with an HRP2-positive/pan-lactate dehydrogenase-positive (HRP2/
pLDH) result, 94 (34.1%) with an HRP2/pLDH-negative (pLDH) result, and 58 (21%)
with a negative RDT result (see Fig. S1 in the supplemental material). Demographic
and clinical characteristics of the cohort are shown in Table 1. Notably, subjects with
TABLE 1 Baseline demographic and clinical characteristics stratified by RDT result
Parametera
Value for the parameter by RDT result
P valueAll HRP2/pLDH HRP2/pLDH Negative
Baseline characteristics
No. of patients (%) 276 124 (44.9) 94 (34.1) 58 (21.0)
Median age (yr [IQR]) 13 (7–22) 12 (7–17.5) 14.5 (8–27) 18 (4–40) 0.002
Age (no. of patients [IQR])
15 yr 106 (39.0) 36 (29.0) 42 (44.7) 28 (51.9)
5–15 yr 122 (48.9) 72 (58.1) 40 (42.6) 10 (18.5) 0.001
5 yr 44 (16.2) 16 (12.9) 12 (12.8) 16 (29.6)
No. of male subjects (%) 114 (41.9) 62 (50.0) 33 (35.1) 19 (35.1) 0.047
Reported symptoms (no. of
patients [IQR])
Fever 241 (89.6) 119 (92.3) 84 (90.3) 38 (80.9) 0.09
Cough 132 (49.1) 54 (41.9) 55 (59.1) 23 (48.9) 0.04
Rhinorrhea 59 (21.9) 19 (14.7) 30 (32.3) 10 (21.3) 0.008
Vital signs (no. of patients [IQR])
Febrile 35 (14.5) 26 (22.6) 7 (7.8) 2 (5.4) 0.003
Tachycardic 64 (25.5) 47 (38.8) 16 (17.2) 1 (2.7) 0.001
Tachypneic 39 (15.4) 24 (19.7) 4 (4.4) 11 (26.8) 0.001
aIQR, interquartile range.
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HRP2/pLDH results were significantly younger, disproportionately male, and more
likely to be febrile and tachycardic at presentation than other patients.
Corresponding thin and thick blood films were available for all patients. P. falcipa-
rum was the predominant Plasmodium species identified by microscopy, accounting for
more than 97% of infections (Table 2). The geometric mean parasite density (GMPD)
was 4,410 parasites/l (95% confidence interval [CI], 3,120 to 6,449 parasites/l) or
approximately 0.1% (Fig. S2). The overall sensitivity of the RDT compared to that of
microscopy was 100% (95% CI, 96.8 to 100.0%), while the specificity was 44.3% (95% CI,
35.7 to 53.2%) (Table 3). The sensitivity of the pLDH antigen band was 78.6% (95% CI,
70.9 to 84.8%), and the specificity was 92.4% (95% CI, 86.1 to 96.1%). The pLDH antigen
TABLE 2 Plasmodium species distribution by diagnostic assay type and microscopy and
PCR positive results stratified by RDT result
Test type(s) and group or
result
No. (%) of positive results by:
RDT Microscopy PCR
All assays for Plasmodium
Total 218 (79.0) 149 (54.0) 156 (56.5)
P. falciparum 145 (52.5) 150 (54.4)
P. malariae 1 (0.4) 0 (0)
P. ovale 2 (0.7) 2 (0.7)
P. falciparum and P. malariae 1 (0.4) 1 (0.4)
P. falciparum and P. ovale 0 (0) 3 (1.5)
RDT for P. falciparum malaria
Total 218 (79.0) 146 (52.9) 154 (55.8)
HRP2/pLDH 124 (44.9) 114 (91.9)a 118 (95.2)b
HRP2/pLDH 94 (34.1) 32 (34.0)c 35 (37.2)d
Negative 58 (21.0) 0 (0.0) 1 (1.7)e
aDoes not include one P. malariae infection.
bIncludes three P. falciparum-P. ovale mixed infections.
cIncludes one P. falciparum-P. malariae mixed infection; does not include two P. ovale infections.
dIncludes one P. falciparum-P. malariae mixed infection; does not include one P. ovale infection.
eDoes not include one P. ovale infection.
TABLE 3 Summary of test performance data for different diagnostic testing strategies for
all patients and for different age categoriesa
Test strategy and age
group Sensitivity (%) Specificity (%) Positive LRb Negative LR
HRP2/pLDH RDT
All patients 99.4 (95.9–100) 46.7 (37.7–55.9) 1.9 (1.6–2.2) 0.01 (0.0020.1)
15 yr 98.1 (88.6–99.9) 50.9 (37.0–64.8) 2.0 (1.5–2.6) 0.04 (0.005–0.3)
5–15 yr 100 (94.5–100) 25.6 (13.6–42.4) 1.4 (1.1–1.6) 0
5 yr 100 (78.1–100) 61.6 (40.7–79.0) 2.6 (1.6–4.2) 0
pLDH RDT
All patients 76.6 (69.0–82.9) 95.1 (89.2–98.0) 15.6 (7.1–34.2) 0.3 (0.2–0.3)
15 yr 66.0 (56.1–74.8) 98.1 (88.6–99.9) 35 (5.0–246.2) 0.4 (0.2–0.5)
5–15 yr 80.7 (70.2–88.3) 87.1 (71.8–95.2) 6.3 (2.8–14.4) 0.2 (0.1–0.5)
5 yr 88.9 (63.9–98.1) 100 (84.0–100) 0.1 (0.03–0.4)
Expert microscopy
All patients 92.2 (86.4–95.7) 95.9 (90.3–98.5) 22.7 (9.6–53.6) 0.08 (0.05–0.1)
15 yr 83.0 (69.7–91.5) 96.2 (85.9–99.3) 22 (5.6–86.1) 0.2 (0.1–0.3)
5–15 yr 95.2 (87.5–98.4) 92.3 (78.0–98.0) 12.4 (4.2–36.7) 0.05 (0.02–0.1)
5 yr 100 (78.1–100) 100 (84.0–100) 0
Two-step algorithm
All patients 95.5 (90.5–98.0) 91.0 (84.1–95.2) 10.6 (6.0–18.6) 0.05 (0.02–0.1)
15 yr 90.6 (78.6–96.5) 94.3 (83.4–98.5) 16.0 (5.3–48.2) 0.1 (0.04–0.2)
5–15 yr 97.5 (90.8–99.6) 84.6 (68.8–93.6) 6.3 (3.0–13.3) 0.03 (0.007–0.1)
5 yr 100 (78.1–100) 100 (84.0–100) 0
aValues in parentheses are 95% confidence intervals.
bLR, likelihood ratio.
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band did demonstrate improved sensitivity with increasing parasite density (Fig. 1), but
the sensitivity remained less than 60% below a threshold of 2,500 parasites/l.
In the primary analysis, we found that the sensitivity and specificity of the RDT
compared to results with real-time PCR were 99.4% (95% CI, 95.9 to 100.0%) and 46.7%
(95% CI, 37.7 to 55.9%), respectively. The HRP2/pLDH results were responsible for 59
of 65 (90.8%) false-positive tests (Table 2). The sensitivity of the pLDH antigen band was
76.6% (95% CI, 69.0 to 82.9%), and the specificity was 95.1% (95% CI, 89.2 to 98.0%).
Notably, the pLDH band performed well in children of 5 years of age, where the
sensitivity and specificity were 88.9% (95% CI, 63.9 to 98.1%) and 100% (95% CI, 84.0 to
100.0%), respectively (Table 3).
We estimated the test performance of a two-step diagnostic algorithm in which
patients with HRP2/pLDH results would be treated without further testing, while
those with HRP2/pLDH results were considered indeterminate and thus subject to
confirmatory testing via microscopy (Fig. 2). After this algorithm was applied to our
cohort, the overall sensitivity compared to that of real-time PCR was 95.5% (95% CI, 90.5
to 98.0%), and the specificity was 91.0% (95% CI, 84.1 to 95.2%). The specificity was
similar and significantly better than that of the multiple-antigen RDT across each of the
age strata (Table 3).
Demographic and clinical characteristics of the seven patients with a positive PCR
who were not identified by the algorithm are shown in Table 4. We attempted to
quantify the parasite density of these submicroscopic infections using an LDH-based
quantitative PCR (qPCR) from DNA extracted from the RDT, but the level of parasitemia
was below the level of detection, which is generally considered 10 parasites/l (15).
However, we were able to confirm the initial real-time PCR results using the highly
FIG 1 Graph demonstrating that the sensitivity of the pLDH antigen band increases with higher parasite density infections, plateauing near 80% when patients
with parasitemia of 100,000 parasites/l or more were considered.
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sensitive var gene acidic terminal sequence (ATS) assay, results of which were again
positive for P. falciparum DNA (Table 4). Notably, none of these individuals met the
criteria for severe malaria, and five of six for whom records were available were
discharged with oral antimalarial therapy.
DISCUSSION
A multiple-antigen (HRP2/pLDH) rapid diagnostic test showed high sensitivity
(99.4%) but poor specificity (46.7%) for the diagnosis of malaria at a peripheral health
center in western Uganda. Nearly two-thirds (59 of 94) of HRP2/pLDH RDT results
were false positives. These findings suggest that the use of HRP2-based RDTs in
high-transmission settings will lead to the overestimation of malaria incidence and the
inappropriate prescription of antimalarial therapies, while possibly contributing to the
undertreatment of other causes of febrile illness (9).
While other studies have reported ranges of HRP2 specificity from 55% to 88% at
high-transmission sites in Uganda (16–20), our results suggest that the specificity may
be even lower than previously described. The most likely explanation for these findings
is the persistence of HRP2 antigenemia following treatment of an acute infection. A
recent study from southwestern Uganda demonstrated that the median time to a
negative HRP2 RDT after treatment was between 35 and 42 days, with more than a
quarter of individuals remaining positive at the end of the 6-week study period (21).
Another study from eastern Uganda reported HRP2 persistence in approximately half of
cases 1 month after treatment (18).
An alternative explanation, at least when microscopy is utilized as the reference
standard, is the presence of submicroscopic parasitemia. For example, a study looking
at the performance of RDTs across six sites in Uganda found that approximately 56% of
FIG 2 Test performance of proposed two-step diagnostic algorithm using HRP2/pLDH rapid diagnostic tests as the initial screen and microscopy as confirmatory
testing for HRP2/pLDH results, which show a high rate of false positivity. Sens, sensitivity; Spec, specificity.
TABLE 4 Demographic and clinical characteristics of patients misdiagnosed by the two-step diagnostic testing algorithm
Patient
age (yr)
Patient
sexa
Diagnostic result Patient clinical datad
RDTb Microscopy
18S rRNA
PCR
var ATS
PCRc CT Temp (°C) HR
SBP
(mm of Hg) SpO2 (%) Hb (g/dl)
Lactate
(mmol/liter)
14 F HRP2/pLDH Negative P. falciparum P. falciparum 35.0 37.3 123 104 98 12.8 0.8
15 M HRP2/pLDH Negative P. falciparum P. falciparum 36.2 38.0 101 84 98 12.6 1.4
20 M HRP2/pLDH Negative P. falciparum P. falciparum 37.4 36.4 67 116 93 14.4 1.2
21 M HRP2/pLDH Negative P. falciparum P. falciparum 40.2 36.3 78 138 98 15.2 1.5
25 F HRP2/pLDH Negative P. falciparum P. falciparum 41.9 37.4 116 119 96 11.9 1.9
48 F Negative Negative P. falciparum 78 114 99
77 F HRP2/pLDH Negative P. falciparum P. falciparum 37.6 35.9 95 141 95 14.6 1.8
aF, female; M, male.
bRDT, rapid diagnostic test.
cvar ATS PCR was performed on DNA extracted from RDTs rather than DBS.
dCT, threshold cycle; Temp, oral temperature; HR, heart rate in beats per min; SBP, systolic blood pressure; SpO2, oxygen saturation as determined by pulse oximetry;
Hb, hemoglobin; lactate, venous lactate. Values in bold represent abnormal findings.
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HRP2-positive/pLDH-negative and microscopy-negative results were subsequently pos-
itive by PCR, suggesting submicroscopic parasitemia (16). However, in our cohort 90%
(54 of 60) of these individuals were also PCR negative, which is more consistent with
HRP2 persistence.
The specificity of the pLDH antigen band was significantly better than that of the
HRP2 band (95.1 versus 46.7%; P  0.001). However, the pLDH antigen band suffered
from decreased sensitivity, especially at lower parasite densities. Given the high mor-
bidity and mortality associated with untreated malaria, a sensitivity of 76.6% is likely
insufficient for routine use. Our results, however, do suggest that pLDH-based RDTs
may be a reasonable choice for children less than 5 years of age (sensitivity, 88.9%;
specificity, 100%).
With two imperfect antigens, an RDT-based diagnostic strategy in a high-transmission
setting represents largely a trade-off between sensitivity and specificity. A two-step
diagnostic approach combining a multiple-antigen RDT and microscopy may mitigate
these limitations while still taking advantage of the low cost and ease of use of the RDT.
The overall sensitivity and specificity of this algorithm compared to PCR results were
95.5% and 91.0%, respectively. This estimate represents a large improvement in spec-
ificity (91.0% versus 46.6%; P  0.001), with minimal loss of sensitivity (95.5% versus
99.4%; P  0.004). Importantly, none of the misclassified cases showed signs or
symptoms of severe malaria, and most harbored very low density infections.
One advantage of a two-step approach is that there would be little implementation
cost as both RDT and microscopy are widely employed for the diagnosis of malaria. For
peripheral health facilities without microscopy capabilities, the cost of such a strategy
would be the additional time and resources required to implement microscopy for the
subset of patients with indeterminate HRP2/pLDH results. These costs would have to
be weighed against the benefit of a reduction in artemisinin overtreatment. For
example, among the larger RDT for Severe Malaria (RDTSM) cohort, 917 of 6,641 (13.8%)
patients had an HRP2/pLDH RDT result. If approximately two-thirds of these results
are false positives that can be confirmed with microscopy, there is a reduction of about
600 artemisinin doses, which represents nearly a 25% decrease in the amount of antima-
larial treatment given over the course of the study.
For facilities that currently utilize microscopy as the primary means of malaria
diagnosis, the cost would be that of adding an HRP2/pLDH RDT screening step.
Assuming that microscopy quality is reasonable, the benefit for these sites may not be
a reduction in ACT overtreatment but, rather, a significant decrease in the number of
smears performed, with a resulting increase in the proportion of parasitologically
confirmed diagnoses and in overall laboratory throughput. For example, our previous
work suggests that replacing microscopy with RDTs as the primary method of malaria
diagnosis can result in a 2- to 3-fold increase in laboratory throughput, with a similar
increase in the proportion of patients receiving a parasite-based diagnosis (22). Our
model, however, which utilized expert microscopy with accuracy similar to that of PCR
(sensitivity, 92.2% [95% CI, 86.5 to 95.7%]; specificity, 95.9% [95% CI, 90.2 to 98.5%]),
may not accurately reflect real-world conditions (23, 24). Undoubtedly, with decreasing
microscopy skill, especially with lower-density infections, the potential benefits could
be lost. Prospective studies evaluating the accuracy and cost of this algorithm in routine
practice are needed.
The two-step diagnostic algorithm combining a multiple-antigen RDT and micros-
copy is only suitable for high-transmission areas where P. falciparum is the predominant
malaria species. As transmission intensity declines, there will be fewer infections, and
the prevalence of posttreatment HRP2 antigenemia within the population should
decline. Under these conditions, HRP2 RDTs perform with both high sensitivity and
specificity, and the addition of a pLDH antigen band contributes very little to improved
test performance. The proposed algorithm would also be confounded in areas where
non-P. falciparum infections are common as the pLDH antigen band could not reliably
serve as a semiquantitative marker of parasitemia.
The strengths of the study include the use of highly sensitive molecular measures as
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the reference standard, the incorporation of demographic and clinical data in the
analysis, and the modeling of a two-step algorithm to improve malaria diagnosis. The
study also has a number of limitations. Our sample size was relatively small (n  276),
and the method of sample selection was purposeful rather than random, which may
have introduced an element of selection bias and limits the generalizability. We are
reassured that, by using data from the larger study, we did not find significant
differences in baseline characteristics, including age (P  0.56), sex (P  0.86), and the
proportion of individuals who were febrile at presentation (P  0.91), between those
patients who were sampled and those who were not.
Additionally, we deferred initial testing decisions to the clinical staff rather than
having strict inclusion criteria. This approach better reflects current practice in Uganda
but may have at times resulted in inappropriate testing decisions. We also did not
confirm the presence of alternative causes of illness, such as viral or bacterial infections,
which leaves us unable to discriminate clinical from subclinical malaria. We attempted
to account for these limitations by using rigorous statistical methods and considering
every patient with confirmed parasitemia to be a case for the purposes of diagnosis.
While our results show lower specificity than other studies, the results are not far from
previous estimates, and we have no reason to believe there were technical or storage
issues with the RDT.
Conclusions. HRP2 antigen bands demonstrated poor specificity for the diagnosis
of malaria compared to results with both microscopy and real-time PCR in a high-
transmission setting. The most likely explanation for this finding is the persistence of
HRP2 antigenemia following treatment of an acute infection. Potential implications
include overtreatment with ACT and undertreatment of other causes of febrile illness.
The two-step diagnostic algorithm utilizing microscopy as a confirmatory test for
indeterminate HRP2/pLDH results showed significantly improved specificity with
little loss of sensitivity. Implementation of such an approach would require little
additional investment beyond currently employed resources. Prospective studies
evaluating this algorithm in routine practice, however, are needed.
MATERIALS AND METHODS
Study setting. The Bugoye Level III Health Center (BHC) in the Kasese District of western Uganda
(0°18=N, 30°5=E) functions as the referral center for the Bugoye subcounty, serving a rural population of
approximately 50,000 residents. Clinical officers, nurses, midwives, and laboratory technicians employed
by the Ugandan Ministry of Health staff the health center, and care is provided at no cost to patients.
Malaria RDTs were first introduced at BHC in 2011 (22). The climate in Bugoye permits year-round malaria
transmission marked by semiannual transmission peaks, typically following the end of the rainy seasons.
The two most recent malaria indicator surveys undertaken in the region found parasite rates of 48.4% in
2009 and 17.6% in 2014 (25, 26), while our previous facility-based work has found test positivity rates that
can reach upwards of 60% (27).
Study design. The Rapid Diagnostic Tests for Severe Malaria (RDTSM) study was a prospective,
observational cohort study of patients presenting to a rural health center with fever or other symptoms
suspicious for malaria as determined by the clinical staff. The objective of the study was to assess the
accuracy of a multiple-antigen RDT compared to WHO-defined clinical and laboratory criteria to identify
patients with severe malaria (28, 29).
Initial testing for malaria was performed using the Standard Diagnostics 05FK60 Malaria Ag P.f/Pan
assay (Standard Diagnostics, Hagal-Dong, South Korea). The RDT is a validated, antigen detection test
with three individual bands signifying the control, the histidine-rich protein 2 (HRP2), and the pan-lactate
dehydrogenase (pLDH) antigens (30–32). The monoclonal HRP2 antibody coated on the RDT membrane
is specific to P. falciparum, while the pLDH antibody will complex with LDH antigen of P. falciparum,
Plasmodium malariae, Plasmodium ovale, and Plasmodium vivax.
The presence of a single HRP2 line (here referred to as a HRP2/pLDH result) is intended to denote
infection with P. falciparum, whereas a single pLDH line (HRP2/pLDH) is designed to indicate infection
with one or more of the other Plasmodium species. The presence of a positive HRP2 line together with
a pLDH line (HRP2/pLDH) indicates either P. falciparum infection or a mixed-species infection. All RDTs
were obtained directly from the manufacturer, stored in the original packaging at ambient temperature,
and utilized prior to the expiry date. RDTs were performed in accordance with the manufacturer’s
instructions.
Study staff prepared thin and thick blood smears for all individuals with a positive RDT result and
approximately 15% of individuals with a negative RDT result. Smears were fixed with methanol and
packaged with silica gel prior to transportation and stained in 10% Giemsa at the Epicentre Mbarara
Research Centre. Slides were reviewed by experienced microscopists, who were blinded to the field
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results. Asexual parasitemia of any level was reported as a positive smear. We examined 200 oil
immersion fields with a 100 objective prior to reporting a negative result, following WHO/Tropical
Disease Research (TDR) guidelines (33). Two independent microscopists read all slides. A third, senior
microscopist resolved discrepancies between the first two reads.
As a substudy nested within RDTSM, we performed real-time PCR on approximately 5% of study
participants in order to estimate the accuracy of slide reading. From 11 August to 10 September 2015,
we collected dried blood spots (DBS) (Whatman, Chicago, IL) from study participants. DBS were
generated by blotting 50 l of blood on the filter paper and allowing it to dry at room temperature. DBS
were individually packaged with desiccant and stored at room temperature until extraction. Sampling
was based on RDT result to ensure a distribution of RDT results, with a goal of obtaining approximately
twice the number of HRP2/pLDH and HRP2/pLDH results as negative results.
Molecular analysis of the DBS was completed at the Epicentre Mbarara Research Centre. DNA
extraction was performed using a QIAamp DNA minikit (Qiagen, Hilden, Germany) in accordance with the
manufacturer’s instructions. Real-time PCR primer and probe sequences detecting small-subunit 18S
rRNA genes were selected from previously a published protocol using a Rotor-Gene Q cycler (Qiagen,
Hilden, Germany) although we modified this protocol for DBS (34). Plasmodium species identification was
accomplished by analysis of high-resolution melting curves and comparison of the thermal profile to that
of positive controls (35).
As confirmation of the 18S rRNA PCR results for the individuals who were PCR positive but were not
identified by the proposed diagnostic testing algorithm, we performed DNA extraction from the stored
RDT using a previously described protocol (36). After confirmation of successful extraction via Qubit
fluorescence (Thermo Fisher Scientific, Waltham, MA, USA), quantitative PCR was attempted to detect the
P. falciparum LDH (PfLDH) loci (37). Upon amplification of positive controls but failure of experimental
samples, the protocol was adjusted to accommodate an increase from the minimum 1 l of DNA to a
maximum of 5 l. Following a second amplification failure, we changed assays to the ultrasensitive
protocol targeting the var ATS sequence for qualitative detection to confirm the presence of P.
falciparum DNA (38).
Statistical analysis. Data were entered into Microsoft Excel (Redmond, WA, USA) and analyzed with
Stata, version 12.1 (College Station, TX, USA). We summarized patient characteristics and compared them
between those with negative, HRP2/pLDH, and HRP2/pLDH RDT results using linear regression for
continuous variables and Pearson’s chi-square testing for categorical variables. Parasite densities were
log transformed and reported as geometric means. We graphically depicted the relationship between
parasite density and age using local polynomial regression (LOESS) (39).
For our primary analysis, we determined the sensitivity and specificity of the multiple-antigen RDT in
comparison to results with real-time PCR for the detection of P. falciparum malaria. Both HRP2/pLDH
and HRP2/pLDH RDT results were considered positive in the primary analysis. We repeated this
analysis using expert microscopy as the reference standard in order to evaluate the relationship between
RDT performance and parasite density. Additionally, we examined the sensitivity and specificity among
different age groups. As a secondary analysis, we examined the independent performance of the pLDH
antigen band by considering HRP2/pLDH RDT results as negatives while still using real-time PCR as the
reference standard.
In a post hoc analysis attempting improve diagnostic specificity, we developed and tested a two-step
algorithm utilizing the multiple-antigen RDT to screen patients, followed by confirmatory microscopy for
those individuals with HRP2/pLDH results. We estimated the sensitivity and specificity of this algo-
rithm and described the demographic, laboratory, and clinical information for the patients who were
positive by PCR but not identified by the two-step algorithm.
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